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Pelvic inﬂammatory disease (PID) is a global health concern that is associated with signiﬁcant morbidity and is a major cause of
infertility. Throughout history animals have been used for anatomical studies and later as models of human disease. In particular,
nonhuman primates (NHPs) have permitted investigations of human disease in a biologically, physiologically, and anatomically
similar system. The use of NHPs as human PID models has led to a greater understanding of the primary microorganisms that
cause disease (e.g., Chlamydia trachomatis and Neisseria gonorroheae), the pathogenesis of infection and its complications, and the
treatment of people with PID. This paper explores historical and contemporary aspects of NHP modeling of chlamydial PID, with
an emphasis on advantages and limitations of this approach and future directions for this research.
1.Introduction
TheCenterforDiseaseControlandPreventionapproximates
that 750,000 women in the United States contract pelvic
inﬂammatory disease (PID) each year and 10% of these cases
result in infertility [1]. It is the ascent of bacterial organisms
totheupperreproductivetractthatcausesPID.Themajority
of PID cases are due to sexually transmitted infections
with Chlamydia trachomatis and Neisseria gonorroheae. C.
trachomatis is a common cause of PID in women and
is usually an asymptomatic infection, which allows the
organism to remain undetected as it ascends into the upper
reproductive tract [2]. High rates of infertility and morbidity
resulting from PID are a global concern [3].
Nonhuman primates (NHPs) have a long history of use
in biomedical research. In the ﬁrst century A.D., Barbary
apes (Macaca sylvan) were likely the ﬁrst primates used
in research [4] .T h e s ea p e sw e r eu s e da sr e p l a c e m e n t sf o r
human cadavers in anatomical studies. In the late 19th
century, recognition of the similarities between humans and
NHPs promoted the usefulness of these animals in research
[5, 6]. In the last hundred years the primate has become
a common research subject in many United States based
laboratories. As this interest evolved, more primate species
were used in biomedical research. Originally, primates were
used strictly as anatomical models, but this evolved to
include studies of disease pathogenesis and the testing of
novel medical technologies. The similarities between the
anatomy and physiology of NHPs and humans have made
such modeling successful [7–9]. The speciﬁc utilization of
NHPs in reproductive studies has occurred more recently
and continues to expand.
In 1950, Te Linde and Scott noted the eﬀectiveness of
using NHPs (rhesus monkey) in the study of endometriosis
[10]. The anatomical and physiologic similarities of NHPs
permitted the modeling of diseases that would otherwise
be impossible, or unethical, in humans. Because no single2 Infectious Diseases in Obstetrics and Gynecology
species of NHP entirely reproduces the pathophysiology of
human disease, various NHPs (marmoset, macaque, grivet,
and baboon) have been used. NHP models of sexually trans-
mitted infections have permitted a better understanding of
disease pathogenesis, the eﬀectiveness of diﬀerent treatment
modalities and have accelerated renewed research interests
in prevention strategies, including topical microbicide and
vaccine development. NHP models of PID, particularly
C. trachomatis-associated PID, have been used for over
ﬁve decades. C. trachomatis has been used to successfully
infect a variety of NHPs: chimpanzees, marmosets, grivets,
macaques,andbaboons[11–15].Primates provideanattrac-
tive model for PID because, unlike other animal models
(sheep,guineapigs,pigs,andmice),NHPreproductivetracts
are of a similar shape and size to those of women [16].
What is more, contemporary NHP PID models employ the
use of human serovars of C. trachomatis to induce PID, as
they are naturally susceptible to infection of the lower and
upper genital tract after challenge. When smaller animal
models are used nonhuman strains, exogenous pretreatment
with hormones as well as use of PID-inducing pathogens
often need to be employed because human-derived bacterial
strains may not cause a similar disease in the particular
animal [17, 18]. This paper presents the current status
of NHP models for the study of experimentally induced
chlamydial PID.
2. The Rationale for NHP Use in
Biomedical Research
In theory, the best model for human disease is the human;
however ethical and practical concerns prohibit many fun-
damental studies. Thus, NHPs serve a unique niche in
biomedical research. The evolutionary closeness that the
NHPs share with Homo sapiens helps ensure biologically
similar models with both predictive and discriminative
abilities unavailable in other animal models [19]. Though
research performed in rodents, and other small animals has
several advantages: lower cost, ease of handling, and the
ability to genetically alter them (e.g., knockout mice), the
results are not always translatable to human disease.
T h eu s eo fN H P si nP I Dm o d e l sh a sb e e na b l et o
successfully fulﬁll Koch’s postulates to prove that Chlamydia
causes PID [12, 14, 20, 21]. NHP models allow for detailed
observations of disease progression, that is, the pathogenesis
of infection, to be studied in vivo. Likewise, one can
eﬀectivelyexaminehostimmuneandphysiologicalresponses
independently from studying microbial pathogenesis [22].
While these advantages are shared with other animals, a
unique advantage of NHPs is their relatively long life span
thatpermits animals tobe reusedin subsequentindependent
studies during their lifetime. In addition, many NHPs
continue their menstrual cycle while in captivity, supporting
their use as reproductive health models. Diﬀerences both
subtle and great have led to the creation of PID models
among diﬀerent species (Table 1).
Though NHPs have numerous advantages they are not
without limitations. Using NHPs is costly, requires adequate
facilities, veterinarian staﬀ support, expertise, and technical
staﬀtocarefortheanimals.And,duetotheincreasingdebate
regarding vivisection, adequate security is imperative.
3. EarlyNHPStudiesof
Chlamydia Pathogenesis
Thygeson, an ophthalmologist, studied ocular chlamydial
infectionsandreportedthatmaternal-to-infanttransmission
induced chlamydial cervicitis (Table 2)[ 11]. Using material
collected from the eye of an infant with inclusion blenn-
orrhea the cervix of two baboons were directly inoculated.
One animal developed a marked cervicitis with purulent
material in the cervical canal at 12 days postinoculation [11].
Thesecondanimalhadnoresponseaftertheﬁrstinoculation.
With a repeated inoculation this animal developed mild
cervicitis but without a purulent discharge. Interestingly,
Thygeson and his colleagues were unable to demonstrate
the detection of inclusion bodies after inoculation in either
animal.
Alexander and colleagues used the Taiwan monkey in a
similar fashion, inoculating the cervix of pregnant monkeys
with TRIC (Table 2)[ 31]. Like Thygeson, they reported mild
erythema of the lower genital tract and were unable to detect
inclusion bodies after inoculation. These early studies were
not designed to model PID and had limited results; but they
provided important foundation for later use of NHPs in PID
modeling.
4. Early NHP Models of Lower GenitalTract
Chlamydia Infection
Johnson et al. used the marmoset to show that an acute
inﬂammatory response reaction occurred with a vaginal
inoculation of C. trachomatis (Table 2)[ 20]. This response
lasted 10–42 days. Acute cervicitis was characterized by
erythema, occasional edema, and the presence of purulent
cervical mucus [35]. A neutrophil-rich leukocyte response
was shown, and chlamydial inclusions were demonstrated
in the epithelium. The lower genital tract response was
characterized using histology and colposcopy. Interestingly,
animals with repeated infection, with either homologous
or heterologous chlamydial strains, had decreased inﬂam-
matory responses, shorter durations of infection and those
that had previous inoculations were able to eliminate the
infection within one week [34].
Nearly all animals in their study developed either an
IgM or IgG antibody response. Despite the number of
reinfections, the highest IgM titer was 1:16 where the IgG
response tended to increase with subsequent inoculations
suggesting that the animals had developed an adaptive
immune response. The focus of this group’s work was study-
ing the lower genital tract, but one case of acute endometritis
and salpingitis was observed histologically upon autopsy.
However, the authors did not have microbiologic studies of
the upper tract prior to autopsy and were unable to identify
intracytoplasmic chlamydial inclusions in epithelial cells.Infectious Diseases in Obstetrics and Gynecology 3
Table 1: List of NHP used in reproductive health research.
Animal Species Average Life
span (years)
Average size
(cm)
Average weight
(kg)
Menstrual
length
(days)∗
Advantages/disadvantages
Olive baboon Papio anubis 25–30 M: 70
F: 60
M: 24
F: 14.7 30–35 [23]
Advantages: anatomical and physiological
closeness to humans, large size (facilitates
procedures), straight cervix, readily avail-
able, non-threatened, can visually mon-
itor cycle stage with greatest precision
Disadvantages: large size and strength,
large housing requirements
African
Green
Monkey
(Vervet,
Grivet)
[24, 25]
Chlorocebus aethiops
(formerly
Cercopithecus
aethiops)
11–13
(captive)
M: 49
F: 42.6
M: 5.5
F: 4.1 30–32 [26]
Advantages: anatomical and physiological
closeness to humans, manageable
size, readily available, non-threatened
Disadvantages: tortuous Cervix, cannot
visually monitor cycle stage
Common
marmoset Callithrix jacchus 12 (wild) M: 18.8
F: 18.5
.350–.450∗
[27] 22–28
Advantages: anatomical and physiological
closeness to humans, manageable
size, readily available, non-threatened
Disadvantages: no menstruation (has
estrus cycle) [4], small size (precludes
certain procedures); ovulation pattern
slightly diﬀerent from humans (twinning
is the normal state), cannot visually
monitor cycle stage
Macaques
Pigtailed Macaca nemestrina 26 M: 49.5–56.4
F: 46.7–56.4
M: 6.2–14.5
F: 4.7–10.9 30–40 [28] Advantages: anatomy of reproductive
tract tissues and physiology of menstrual
cycle similar to humans, size (facilitates
most procedures), non-threatened, can
visually monitor cycle stage to some
degree
Disadvantages: limited availability, some
species are seasonal breeders (rhesus,
possibly Formosan rock macaque),
tortuous cervix, aggressive temperament
(rhesus), zoonotic disease risk
Formosan
rock
macaque
(Taiwan
monkey)
Macaca cyclopis NA 40–55∗ 4–8∗ 24–31
Rhesus Macaca mulatta 25 M: 53.2
F: 46.9
M: 7.7
F: 5.34 28
Cynomolgus Macaca fascicularis 31 M: 41–65
F: 39–50
M: 4.7–8.3
F: 2.5–5.7
28–32
[29, 30]
NA: not available. ∗Diﬀerences between males and females were not noted.
5.Development ofPID inNHPs
Concomitant with Johnson et al.’s work in marmosets,
Moller et al. did similar work in grivet monkeys (Table 2)
[46]. By directly inoculating the fallopian tubes and the
endometrial cavity, grivet monkeys developed acute self-
limited salpingitis. The histological ﬁndings in the tubal
tissues post-inoculation (inﬁltration of the subepithelial and
mucosal epithelium, abundant lymphocytes, and polymor-
phonuclear (PMN) leukocytes, and exudate in the tubal
lumen with small clusters of desquamated epithelium)
mirrored what is considered to be the hallmark signs of
acute salpingitis in women [32]. Moller also showed that
there was an activated immune response associated with
inoculation with C. trachomatis. The antibody response was
that of a primary infection with an IgM to IgG antibody
seroconversion [32]. Additionally, in the animal that was
infected in the endometrial cavity they documented ascent
of the C. trachomatis to the fallopian tubes.
A later study by this same group found that direct
cervical inoculation with C. trachomatis resulted in acute
salpingitis [12]. These ﬁndings conﬁrmed Johnson’s results
in the marmoset. They, too, satisﬁed Koch’s postulates and
reisolated the organism. Again, the cervical infection with
C. trachomatis resulted in “classic” histological ﬁndings for
acute salpingitis as noted in humans, and like the previous
trial,theserologicalconversionseenpostcervicalinoculation
was an IgM to IgG seroconversion.
6. CurrentNHP Models of PID
Using direct tubal inoculation, Patton and colleagues
demonstrated a histopathologically similar acute salpingitis
in the pigtailed macaque to that noted by Moller et al. in the
grivet monkey (Table 2)[ 36, 37]. In the pigtailed macaques
and grivet monkeys a single inoculation of C. trachomatis
resulted in self-limited tubal inﬂammation without evidence4 Infectious Diseases in Obstetrics and Gynecology
Table 2: Historical NHP PID models and the pathological features found with each subsequent trial.
Researcher, Year Animal Chlamydial
inoculum Site of inoculation Pathologic features
Thygeson and
Mengert 1936
[11]
Baboon
Material from
infant with
inclusion
blennorrhea
cervix Cervicitis, purulent cervical discharge
Alexander et al.,
1967 [31] Taiwan monkey TRIC cervix Mild erythema of the lower genital tract
Ripa et al., 1979
[32] Grivet Ct, 2×105 IFU/mL fallopian tube
Histological changes in the upper genital tract, swollen red-
dened tubes, abundant lymphocytes in the tubal epithelium,
clusters of desquamated cells, adhesions between mucosal
folds
Johnson et al.,
1980 [20] Marmoset Ct, 5 ×105 IFU/mL vagina Acute inﬂammatory reaction of the lower genital tract,
PMNs, intracytoplasmic chlamydial inclusions
Moller et al.,
1980 [33] Grivet Ct, 2×105 IFU/mL cervix
Reddened and swollen tubes, exudate from ostia, histo-
logical changes in the upper genital tract, lumen of tube
diminished and tubal epithelium atrophic and ﬂattened,
demonstrated vertical spread of organism
Johnson et al.,
1981 [34] Marmoset Ct, 4.2–
8.8×105 IFU/mL vagina
Demonstrated that reinfection with either homologous or
heterologous strain could result in infection however the
shorter duration between inoculations resulted in marked
immunity and decreased duration of infection
Johnson et al.,
1985 [35] Marmoset Ct, 5 ×105 IFU/mL vagina Cervical erythema with occasional edema, cloudy, or puru-
lent mucus, PMNs identiﬁed, endometritis, and salpingitis
Patton et al.,
1983, 1984
[36, 37]
Pigtailed macaque Ct, 6×106 IFU/mL fallopian tube Acute salpingitis with marked edema and swelling, ﬂoccu-
lent exudate, PMNs, isolation of Ct from cervix and tubes
Patton et al.,
1987 [38]
Cynomolgus
rhesus Ct, 7×106 IFU/mL
Subcutaneous
pocket model with
fallopian tube
implants
Marked erythema, edema, and swelling, widespread inﬂam-
mation with lymphocytic cells and PMNs, and plasma cells
had inﬁltrated the stroma, infection duration shorter than
that seen in intact model with direct tubal inoculation
Patton et al.,
1987 [14] Pigtailed macaque Ct,
2–4×108 IFU/mL fallopian tube Chronic salpingitis with extensive tubal scarring, distal tubal
obstruction, and peritubal adhesions
Patton et al.,
1990 [39] Pigtailed macaque Ct, 1×106 IFU/mL cervix Acute and chronic salpingitis, peritubal adhesions
Wolner-
Hanssen et al.,
1991 [40]
Pigtailed macaque Ct, 1×106 IFU/mL cervix
Demonstrated that repeated cervical inoculation resulted
protective immunity though there was no relationship
between the antibody titer and reinfection
Patton et al.,
1994 [41] Pigtailed macaque Ct, 5×103 IFU/mL
Subcutaneous
pocket model with
fallopian tube
implants
Demonstrated a delayed hypersensitivity in response to
inoculation with Ct in both previously infected pockets and
noninfected pockets
Van Voorhis et
al., 1997 [42] Pigtailed macaque Ct, 1×105 IFU/mL
Subcutaneous
pocket model with
fallopian tube
implants, cervix
and fallopian tubes
Suggests that a Th1-like cytokine response is seen with
repeated infection with Ct
Patton et al.,
2005 [43] Pigtailed macaque Ct, 1×105 IFU/mL cervix Demonstrated the azithromycin treatment in Ct infection
ameliorated the immune response to Ct infection
Patton et al.,
2008, 2009
[44, 45]
Pigtailed macaque Ct, 5×105 IFU/mL vaginal fornix,
rectum
Demonstrated the ability of NHP PID model for evaluating
the safety and eﬃcacy of topical microbicides
Bell et al., 2010
[21] Olive baboon Ct, 1×107 IFU/mL cervix Acute and chronic salpingitis, peritubal adhesions
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of tubal scarring. This inﬂammatory period peaked at day 14
and resolved by days 28–35. However, with repeated inocula-
tionsachronicsalpingitiswithextensivetubalscarring,distal
tubalobstruction,andperitubaladhesionswasinduced[14].
This picture of chronic salpingitis after repeated infec-
tions led Patton and colleagues to develop a subcutaneous
pocket model in cynomolgus, rhesus and pigtailed monkeys
so that the tubal response to infection could be easily moni-
tored[38].Thehistopathologyagainshowedaprogressionof
the inﬂammation of the mucosal and muscular layers as well
as a transition from lymphocytic cells, PMNs, and plasma
cells. Like previous studies this model showed a short-
lived infection that was microbiologically, immunologically,
and histopathologically similar to studies in intact monkeys
where inoculation had occurred directly to the fallopian
tube [36]. An important advantage of the pocket model
is that separate anatomic tubal sites are established and
can be individually manipulated per study design. However,
duration of infection was shorter. Though this model was
successful in studying the kinetics of acute and chronic
chlamydial infection in tubal tissues, the use of the intact
NHP reproductive tract is essential to investigate (scarring
and ﬁbrosis) pathogenesis of Chlamydia-induced PID.
Recognizing that the intact NHP model provided a more
analogous model of human disease Patton and colleagues
investigated how infection ascends from the lower into the
upper reproductive tract. Repeated weekly (×ﬁve weeks)
cervical inoculations in four pig-tailed macaques caused
peritubal adhesions in all four monkeys. In contrast, in
a separate study, after primary cervical inoculation, seven
animals were rechallenged at the cervix only after the cervix
had become culturally negative for two consecutive weeks;
none developed adhesions [39].
With this new model of upper tract infection Patton et al.
hadasystemthatcouldbeusedtoevaluatecellularimmunity
associated with chlamydial infections and chronic immune
responses to infection that are associated with the tubal
damage. Additionally, in another study it was demonstrated
with repeated inoculations (after cessation of infection)
animals had a shorter duration of infection [40]. With
this protective immune response there was no correlation
betweentheantibodytiters(IgG)atthetimeofreinoculation
and the success of reinoculation. Attempting to further
deﬁne the immune response associated with chlamydial
infection Patton et al. used their subcutaneous pocket model
to better understand this association [41]. They showed
the same histological changes in the tubal tissues as seen
in their previous work; however, after resolution with
primary infection several pockets were tested by injection
of rhsp60 (recombinant heat-shock protein 60) or sham
injection. Those pockets that were injected with rhsp60
showed a marked increase in inﬂammation at 24 hours
and an even greater response at 48 hours. After 48 hours
the cellular inﬁltrate consisted primarily of mononuclear
lymphocytes that permeated the submucosal tissues, which
is consistent with a delayed hypersensitivity response [41].
Later, again using the subcutaneous pocket model as well as
cervical/tubal inoculations mRNAs for IFN-γ,I L - 2 ,I L - 6 ,I L -
10, but not IL-4, were isolated from salpingeal tissues [42].
IFN-γ and IL-2 are made by TH1 CD4 T cells, whereas TH2
cells make IL-4. IL-6 and IL-10 are made by both TH1 and
TH2 cells. These results suggested that TH1-like cytokines
are made by repeated infection with C. trachomatis [42].
Recently, Patton et al. have used their model of PID to
evaluate diﬀerent antibiotic treatments for chlamydial infec-
tions [43]. In this study diﬀerent treatment options (doxy-
cycline, azithromycin) were tested versus placebo (untreated
infection). As expected, animals that were in the placebo arm
developed PID. However, in the two treatment arms there
were diﬀerences. Those animals treated with doxycycline
developed inﬂammatory cell proﬁles similar to those of
the untreated animals. In contrast the azithromycin-treated
animals had signiﬁcantly reduced levels of inﬂammatory
inﬁltrates. Azithromycin treatment ameliorated the immune
response and was highly eﬀective in eradicating C. trachoma-
tis from the lower and upper reproductive tract tissues [43].
As a vaccine for C. trachomatis has been not yet
been developed, recent studies have focused on novel ways
to prevent infection. Female-controlled products, such as
microbicides, provide a critical opportunity to prevent
sexually transmitted infections. In 1999, Patton et al. were
awarded a Sexually transmitted Disease Prevention-Primate
Contract designed to comparatively assess the safety of
topical microbicide products to cervical and vaginal tissues
after repeated exposure and to evaluate their eﬃcacy in
preventing cervical chlamydial infection. Over 28 products
have been evaluated (gels, ﬁlms, capsules, etc.) for eﬃcacy,
safety and 9 for prevention of C. trachomatis infection
[44]. Four of the candidate products tested were associated
with tissue abnormalities that included epithelial friability,
abrasion, and disruption [44]. These results demonstrated
early warnings of products with potentially deleterious
cervicovaginal eﬀects, which lead to reformulation of several
products [44]. In the rectal safety and eﬃcacy studies,
12 products have been evaluated for safety and one was
additionally tested for eﬃcacy against rectal chlamydial
infection. Two products had an unacceptable safety proﬁle,
and no protection was observed in prevention of acquisition
of rectal chlamydial infection [45].
Until recently, the baboon had not been used in PID
models. It is probable that the size, strength, temperament,
and space required to use these animals have limited their
use. However, next to the great apes (chimpanzee, gorilla,
orangutan), the baboon is the animal most similar to
humans in reproductive anatomy, physiology, and biochem-
istry, including hormonal ﬂuctuations and cycling [47].
Another beneﬁt of the baboon is that they have a straight
(rectilinear) cervical canal, not tortuous like the chimpanzee
and macaque, which permits transcervical procedures (i.e.,
endometrial sampling, intrauterine contraception place-
ment) in a manner that mirrors practice in women [8].
Given this similarity to humans, the baboon has been used
in vaccine trials for C. trachomatis [48]. As mentioned above
one of the earliest trials to use C. trachomatis in baboons
was in the 1930s by Thygeson and Mengert, [11]. Those
trials showed that the baboon could become infected with
C. trachomatis and develop cervicitis. Furthermore, work
by Digiacomo and colleagues showed that the genital tract6 Infectious Diseases in Obstetrics and Gynecology
of male baboons could be infected and continue to shed
chlamydial organisms for approximately 3 months after
initial inoculation [49].
Basedonthestudiespreviouslyconductedinthebaboon,
as well as the Patton model of PID in the macaque, Bell
et al. recently developed a new model of PID in baboons
(Table 2)[ 21]. This work was conducted in wild-caught olive
baboons, and C. trachomatiswas used as the infectious agent.
Bell et al. showed that the baboon was highly susceptible to
C.trachomatis.Moreover,thatwithevenasingleinoculation,
the organism ascended to the upper reproductive tract, as
both Johnson and Moller had shown in their models [21].
Bacteria caused changes consistent with infection in the
upper reproductive tract. Like women with C. trachomatis
infections,theanimalsinthistrialdevelopedvaryingdegrees
of infection, from mild cervicitis to PID. Furthermore, Bell
andcolleaguesdemonstratedthatmultipleinoculationsofC.
trachomatis were able to drive the infection into the upper
reproductive tract (unpublished data), and thus, like the
work of Patton, have established a working model of PID.
7. Discussion
Each of the models of PID above oﬀers investigators the
ability to test scientiﬁc questions in animals that are anatom-
ically, biologically, and physiologically similar to humans.
Although there are a number of animal models, each model
reﬂects some aspect(s) of human disease and appropriate
models that should be utilized to study the desired outcome.
Interestingly, inoculation with C. trachomatis in NHPs does
not lead to infection in all animals, with some animals even
failing to show cervicitis. This observation further supports
the similarity to variable clinical picture that is seen in
women, where some women remain asymptomatic. This
point serves to further strengthen the similarity between the
NHP model of PID and the human disease state. The basis
for this heterogeneity requires further attention.
8. Conclusions
Research concerning PID has progressed greatly in the
past century and continues to advance each year. The use
of NHPs has allowed and will continue to allow for a
greater understanding of the disease. Through the ethical
and humane use of NHP models, the ﬁeld of reproductive
infectious disease has continued to improve our scientiﬁc
understanding of the disease and has helped to improve
treatment measures. The continued use of these models will
allow for investigators to answer questions about human
disease that cannot be easily studied in humans.
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